
### [MONDO:0020247](http://purl.obolibrary.org/obo/MONDO_0020247)
**Label:** congenital vitreoretinal dysplasia

**Subclasses:** [MONDO:0014101](http://purl.obolibrary.org/obo/MONDO_0014101) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12), [MONDO:0013157](http://purl.obolibrary.org/obo/MONDO_0013157) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5), [MONDO:0009097](http://purl.obolibrary.org/obo/MONDO_0009097) (persistent hyperplastic primary vitreous, autosomal recessive), [MONDO:0013158](http://purl.obolibrary.org/obo/MONDO_0013158) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6), [MONDO:0014120](http://purl.obolibrary.org/obo/MONDO_0014120) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13), [MONDO:0014022](http://purl.obolibrary.org/obo/MONDO_0014022) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10), [MONDO:0018068](http://purl.obolibrary.org/obo/MONDO_0018068) (trisomy 13), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9), [MONDO:0019631](http://purl.obolibrary.org/obo/MONDO_0019631) (persistent hyperplastic primary vitreous), [MONDO:0013154](http://purl.obolibrary.org/obo/MONDO_0013154) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2), [MONDO:0009678](http://purl.obolibrary.org/obo/MONDO_0009678) (Fukuyama congenital muscular dystrophy), [MONDO:0013835](http://purl.obolibrary.org/obo/MONDO_0013835) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 7), [MONDO:0010269](http://purl.obolibrary.org/obo/MONDO_0010269) (Coats disease), [MONDO:0015026](http://purl.obolibrary.org/obo/MONDO_0015026) (cerebroretinal microangiopathy with calcifications and cysts 2;), [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0010691](http://purl.obolibrary.org/obo/MONDO_0010691) (Norrie disease), [MONDO:0014071](http://purl.obolibrary.org/obo/MONDO_0014071) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11), [MONDO:0019101](http://purl.obolibrary.org/obo/MONDO_0019101) (retinal capillary malformation), [MONDO:0009820](http://purl.obolibrary.org/obo/MONDO_0009820) (osteoporosis-pseudoglioma syndrome), [MONDO:0009667](http://purl.obolibrary.org/obo/MONDO_0009667) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3), [MONDO:0012815](http://purl.obolibrary.org/obo/MONDO_0012815) (Coats plus syndrome), [MONDO:0013904](http://purl.obolibrary.org/obo/MONDO_0013904) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8), [MONDO:0010631](http://purl.obolibrary.org/obo/MONDO_0010631) (Bloch-Sulzberger syndrome), [MONDO:0012653](http://purl.obolibrary.org/obo/MONDO_0012653) (PHPVAD), [MONDO:0011604](http://purl.obolibrary.org/obo/MONDO_0011604) (Spondylo-ocular syndrome), 

**Mapped go classes:** [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0061299](http://purl.obolibrary.org/obo/GO_0061299) (retina vasculature morphogenesis in camera-type eye), [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:0007252](http://purl.obolibrary.org/obo/GO_0007252) (I-kappaB phosphorylation), [GO:0007250](http://purl.obolibrary.org/obo/GO_0007250) (activation of NF-kappaB-inducing kinase activity), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0007016](http://purl.obolibrary.org/obo/GO_0007016) (cytoskeletal anchoring at plasma membrane), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0097363](http://purl.obolibrary.org/obo/GO_0097363) (protein O-GlcNAc transferase activity), [GO:0005109](http://purl.obolibrary.org/obo/GO_0005109) (frizzled binding), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0016010](http://purl.obolibrary.org/obo/GO_0016010) (dystrophin-associated glycoprotein complex), [GO:0070567](http://purl.obolibrary.org/obo/GO_0070567) (cytidylyltransferase activity), [GO:0061061](http://purl.obolibrary.org/obo/GO_0061061) (muscle structure development), [GO:0030145](http://purl.obolibrary.org/obo/GO_0030145) (manganese ion binding), [GO:0016773](http://purl.obolibrary.org/obo/GO_0016773) (phosphotransferase activity, alcohol group as acceptor), [GO:1904100](http://purl.obolibrary.org/obo/GO_1904100) (positive regulation of protein O-linked glycosylation), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0043113](http://purl.obolibrary.org/obo/GO_0043113) (receptor clustering), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0043236](http://purl.obolibrary.org/obo/GO_0043236) (laminin binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0031505](http://purl.obolibrary.org/obo/GO_0031505) (fungal-type cell wall organization), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0043085](http://purl.obolibrary.org/obo/GO_0043085) (positive regulation of catalytic activity), [GO:0051650](http://purl.obolibrary.org/obo/GO_0051650) (establishment of vesicle localization), [GO:0035426](http://purl.obolibrary.org/obo/GO_0035426) (extracellular matrix-cell signaling), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0098505](http://purl.obolibrary.org/obo/GO_0098505) (G-rich strand telomeric DNA binding), [GO:0035269](http://purl.obolibrary.org/obo/GO_0035269) (protein O-linked mannosylation), [GO:0010389](http://purl.obolibrary.org/obo/GO_0010389) (regulation of G2/M transition of mitotic cell cycle), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0090399](http://purl.obolibrary.org/obo/GO_0090399) (replicative senescence), [GO:0015012](http://purl.obolibrary.org/obo/GO_0015012) (heparan sulfate proteoglycan biosynthetic process), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0044332](http://purl.obolibrary.org/obo/GO_0044332) (Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:0048536](http://purl.obolibrary.org/obo/GO_0048536) (spleen development), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0048539](http://purl.obolibrary.org/obo/GO_0048539) (bone marrow development), [GO:0043403](http://purl.obolibrary.org/obo/GO_0043403) (skeletal muscle tissue regeneration), [GO:0048538](http://purl.obolibrary.org/obo/GO_0048538) (thymus development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0097584](http://purl.obolibrary.org/obo/GO_0097584) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt2p dimer complex), [GO:0097583](http://purl.obolibrary.org/obo/GO_0097583) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt3p dimer complex), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0097585](http://purl.obolibrary.org/obo/GO_0097585) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt3p dimer complex), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0042162](http://purl.obolibrary.org/obo/GO_0042162) (telomeric DNA binding), [GO:0060828](http://purl.obolibrary.org/obo/GO_0060828) (regulation of canonical Wnt signaling pathway), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0042285](http://purl.obolibrary.org/obo/GO_0042285) (xylosyltransferase activity), [GO:0016233](http://purl.obolibrary.org/obo/GO_0016233) (telomere capping), [GO:0071712](http://purl.obolibrary.org/obo/GO_0071712) (ER-associated misfolded protein catabolic process), [GO:0030247](http://purl.obolibrary.org/obo/GO_0030247) (polysaccharide binding), [GO:0050905](http://purl.obolibrary.org/obo/GO_0050905) (neuromuscular process), [GO:0015020](http://purl.obolibrary.org/obo/GO_0015020) (glucuronosyltransferase activity), [GO:0000723](http://purl.obolibrary.org/obo/GO_0000723) (telomere maintenance), [GO:0060538](http://purl.obolibrary.org/obo/GO_0060538) (skeletal muscle organ development), [GO:0043531](http://purl.obolibrary.org/obo/GO_0043531) (ADP binding), [GO:0008299](http://purl.obolibrary.org/obo/GO_0008299) (isoprenoid biosynthetic process), [GO:0007525](http://purl.obolibrary.org/obo/GO_0007525) (somatic muscle development), [GO:0001782](http://purl.obolibrary.org/obo/GO_0001782) (B cell homeostasis), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0047223](http://purl.obolibrary.org/obo/GO_0047223) (beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0071425](http://purl.obolibrary.org/obo/GO_0071425) (hematopoietic stem cell proliferation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0008385](http://purl.obolibrary.org/obo/GO_0008385) (IkappaB kinase complex), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:0047349](http://purl.obolibrary.org/obo/GO_0047349) (D-ribitol-5-phosphate cytidylyltransferase activity), [GO:0006487](http://purl.obolibrary.org/obo/GO_0006487) (protein N-linked glycosylation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:1902236](http://purl.obolibrary.org/obo/GO_1902236) (negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:0060049](http://purl.obolibrary.org/obo/GO_0060049) (regulation of protein glycosylation), [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0042975](http://purl.obolibrary.org/obo/GO_0042975) (peroxisome proliferator activated receptor binding), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0032527](http://purl.obolibrary.org/obo/GO_0032527) (protein exit from endoplasmic reticulum), [GO:0019200](http://purl.obolibrary.org/obo/GO_0019200) (carbohydrate kinase activity), [GO:0050518](http://purl.obolibrary.org/obo/GO_0050518) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0033292](http://purl.obolibrary.org/obo/GO_0033292) (T-tubule organization), [GO:0006493](http://purl.obolibrary.org/obo/GO_0006493) (protein O-linked glycosylation), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:1900101](http://purl.obolibrary.org/obo/GO_1900101) (regulation of endoplasmic reticulum unfolded protein response), [GO:0043276](http://purl.obolibrary.org/obo/GO_0043276) (anoikis), [GO:0097582](http://purl.obolibrary.org/obo/GO_0097582) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt2p dimer complex), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0000030](http://purl.obolibrary.org/obo/GO_0000030) (mannosyltransferase activity), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:0019276](http://purl.obolibrary.org/obo/GO_0019276) (UDP-N-acetylgalactosamine metabolic process), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0014706](http://purl.obolibrary.org/obo/GO_0014706) (striated muscle tissue development), [GO:0030210](http://purl.obolibrary.org/obo/GO_0030210) (heparin biosynthetic process), [GO:0016203](http://purl.obolibrary.org/obo/GO_0016203) (muscle attachment), [GO:0046716](http://purl.obolibrary.org/obo/GO_0046716) (muscle cell cellular homeostasis), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0043047](http://purl.obolibrary.org/obo/GO_0043047) (single-stranded telomeric DNA binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0046835](http://purl.obolibrary.org/obo/GO_0046835) (carbohydrate phosphorylation), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0004169](http://purl.obolibrary.org/obo/GO_0004169) (dolichyl-phosphate-mannose-protein mannosyltransferase activity), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0050650](http://purl.obolibrary.org/obo/GO_0050650) (chondroitin sulfate proteoglycan biosynthetic process), [GO:0005801](http://purl.obolibrary.org/obo/GO_0005801) (cis-Golgi network), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0045111](http://purl.obolibrary.org/obo/GO_0045111) (intermediate filament cytoskeleton), [GO:0072686](http://purl.obolibrary.org/obo/GO_0072686) (mitotic spindle), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0010833](http://purl.obolibrary.org/obo/GO_0010833) (telomere maintenance via telomere lengthening), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0030166](http://purl.obolibrary.org/obo/GO_0030166) (proteoglycan biosynthetic process), [GO:0016779](http://purl.obolibrary.org/obo/GO_0016779) (nucleotidyltransferase activity), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0009101](http://purl.obolibrary.org/obo/GO_0009101) (glycoprotein biosynthetic process), [GO:0008375](http://purl.obolibrary.org/obo/GO_0008375) (acetylglucosaminyltransferase activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0000922](http://purl.obolibrary.org/obo/GO_0000922) (spindle pole), [GO:0008378](http://purl.obolibrary.org/obo/GO_0008378) (galactosyltransferase activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0008376](http://purl.obolibrary.org/obo/GO_0008376) (acetylgalactosaminyltransferase activity), [GO:0046329](http://purl.obolibrary.org/obo/GO_0046329) (negative regulation of JNK cascade), [GO:0060059](http://purl.obolibrary.org/obo/GO_0060059) (embryonic retina morphogenesis in camera-type eye), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0048747](http://purl.obolibrary.org/obo/GO_0048747) (muscle fiber development), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:1990879](http://purl.obolibrary.org/obo/GO_1990879) (CST complex), [GO:0032211](http://purl.obolibrary.org/obo/GO_0032211) (negative regulation of telomere maintenance via telomerase), [GO:0030158](http://purl.obolibrary.org/obo/GO_0030158) (protein xylosyltransferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0120053](http://purl.obolibrary.org/obo/GO_0120053) (ribitol beta-1,4-xylosyltransferase activity), 

**Class expressions from DL-Learner:**

- Thing 55.35%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.71%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 50.71%
- [GO:0005801](http://purl.obolibrary.org/obo/GO_0005801) (cis-Golgi network) 50.71%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 50.71%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.71%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.07%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 36.07%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.07%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 36.07%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 36.07%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005182](http://purl.obolibrary.org/obo/GO_0005182) (obsolete lipopeptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.07%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005181](http://purl.obolibrary.org/obo/GO_0005181) (obsolete glycopeptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.07%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005180](http://purl.obolibrary.org/obo/GO_0005180) (obsolete peptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.07%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005177](http://purl.obolibrary.org/obo/GO_0005177) (obsolete neuroligin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.07%


